10 results on '"NP swab"'
Search Results
2. Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
- Author
-
Cody Callahan, Sarah Ditelberg, Sanjucta Dutta, Nancy Littlehale, Annie Cheng, Kristin Kupczewski, Danielle McVay, Stefan Riedel, James E. Kirby, and Ramy Arnaout
- Subjects
SARS-CoV-2 ,COVID-19 ,saliva ,NP swab ,limit of detection ,Microbiology ,QR1-502 - Abstract
ABSTRACT The continued need for molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting without restrictions to avoid food, drink, smoking, or tooth-brushing. A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity reverse transcriptase PCR (RT-PCR) platforms, the Abbott m2000 and Abbott Alinity m (both with limits of detection [LoD] of 100 copies of viral RNA/ml). Concordance between saliva and NP swabs was excellent overall (Cohen’s κ = 0.93) for both initial and follow-up testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (κ = 0.88 to 0.95). Viral loads were on average 16× higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (∼8% in this study) who present with very low viral loads (
- Published
- 2021
- Full Text
- View/download PDF
3. Cooperation under Pressure: Lessons from the COVID-19 Swab Crisis
- Author
-
Ramy Arnaout
- Subjects
Microbiology (medical) ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,COVID-19 ,cooperation ,Public relations ,NP swab ,Specimen Handling ,Test (assessment) ,Editorial ,Order (exchange) ,Nasopharynx ,General partnership ,Political science ,Joy’s Law ,Pandemic ,Humans ,business ,Pandemics - Abstract
The early months of the COVID-19 pandemic were marked by a desperate need for nasopharyngeal swabs to test for SARS-CoV-2, with demand far outstripping supply. April marked the anniversary of an unprecedented nationwide multibusiness/multihospital partnership that successfully met this need, a fitting occasion to review lessons learned. Here, I briefly recount the key events, constraints, and thought processes surrounding the effort in order to better inform responses to future crises. Overall, the experience was a strong validation of Joy’s Law and illustrated the utility of recognizing temptations to avoid, in order to reap the rewards of cooperation. I conclude by summarizing lessons learned.
- Published
- 2021
4. Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
- Author
-
Annie Cheng, Nancy Littlehale, Stefan Riedel, Kristin Kupczewski, James E. Kirby, Danielle McVay, Sanjucta Dutta, Sarah Ditelberg, Cody Callahan, and Ramy Arnaout
- Subjects
Microbiology (medical) ,Saliva ,Coronavirus disease 2019 (COVID-19) ,Physiology ,Sample (material) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Context (language use) ,Microbiology ,Polymerase Chain Reaction ,Sensitivity and Specificity ,NP swab ,Specimen Handling ,Time ,stomatognathic system ,Nasopharynx ,Genetics ,Medicine ,Humans ,Viral rna ,saliva ,limit of detection ,General Immunology and Microbiology ,Ecology ,business.industry ,Diagnostic Tests, Routine ,SARS-CoV-2 ,COVID-19 ,Cell Biology ,Viral Load ,QR1-502 ,Infectious Diseases ,Specimen collection ,COVID-19 Nucleic Acid Testing ,Immunology ,RNA, Viral ,business ,Viral load ,Research Article - Abstract
The continued need for molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting without restrictions to avoid food, drink, smoking, or tooth-brushing. A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity reverse transcriptase PCR (RT-PCR) platforms, the Abbott m2000 and Abbott Alinity m (both with limits of detection [LoD] of 100 copies of viral RNA/ml). Concordance between saliva and NP swabs was excellent overall (Cohen’s κ = 0.93) for both initial and follow-up testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (κ = 0.88 to 0.95). Viral loads were on average 16× higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (∼8% in this study) who present with very low viral loads (
- Published
- 2021
5. Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2
- Author
-
Ramy Arnaout, Cody Callahan, Kate Zulauf, James E. Kirby, Rose A. Lee, and Ghee Rye Lee
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Emergency Use Authorization ,limit of detection ,nasal swab ,business.industry ,Diagnostic Tests, Routine ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Concordance ,COVID-19 ,NP swab ,Specimen Handling ,Nasal Swab ,Internal medicine ,Nasopharynx ,Virology ,medicine ,Humans ,Sampling (medicine) ,Sample collection ,business ,Viral load ,Kappa - Abstract
The urgent need for large-scale diagnostic testing for SARS-CoV-2 has prompted interest in sample collection methods of sufficient sensitivity to replace nasopharynx (NP) sampling. Nasal swab samples are an attractive alternative; however, previous studies have disagreed over how nasal sampling performs relative to NP sampling. Here, we compared nasal versus NP specimens collected by health care workers in a cohort of individuals clinically suspected of COVID-19 as well as SARS-CoV-2 reverse transcription (RT)-PCR-positive outpatients undergoing follow-up. We compared subjects being seen for initial evaluation versus follow-up, two different nasal swab collection protocols, and three different transport conditions, including traditional viral transport media (VTM) and dry swabs, on 307 total study participants. We compared categorical results and viral loads to those from standard NP swabs collected at the same time from the same patients. All testing was performed by RT-PCR on the Abbott SARS-CoV-2 RealTime emergency use authorization (EUA) (limit of detection [LoD], 100 copies viral genomic RNA/ml transport medium). We found low concordance overall, with Cohen’s kappa (κ) of 0.49, with high concordance only for subjects with very high viral loads. We found medium concordance for testing at initial presentation (κ = 0.68) and very low concordance for follow-up testing (κ = 0.27). Finally, we show that previous reports of high concordance may have resulted from measurement using assays with sensitivity of ≥1,000 copies/ml. These findings suggest nasal-swab testing be used for situations in which viral load is expected to be high, as we demonstrate that nasal swab testing is likely to miss patients with low viral loads.
- Published
- 2021
6. Kappa Values in Testing the Concordance: Comments on a Recent Article about Nasopharyngeal Swabs for SARS-CoV-2 Detection.
- Author
-
Li M, Zhang C, and Yu T
- Subjects
- Humans, Clinical Laboratory Techniques, COVID-19 Testing, Nasopharynx, Specimen Handling, Saliva, SARS-CoV-2, COVID-19 diagnosis
- Published
- 2022
- Full Text
- View/download PDF
7. 3D-Printing to Address COVID-19 Testing Supply Shortages
- Author
-
Cox, Jesse L and Koepsell, Scott A
- Subjects
linical pathology ,0209 industrial biotechnology ,2019-20 coronavirus outbreak ,3D-printing ,Coronavirus disease 2019 (COVID-19) ,Biopsy ,Supply chain ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Clinical Biochemistry ,Economic shortage ,Respiratory Mucosa ,02 engineering and technology ,NP swab ,molecular diagnostics ,03 medical and health sciences ,COVID-19 Testing ,020901 industrial engineering & automation ,0302 clinical medicine ,Nasopharynx ,medicine ,Humans ,030212 general & internal medicine ,Disposable Equipment ,Special Report ,COVID ,Diagnostic Equipment ,Biochemistry, medical ,Clinical Laboratory Techniques ,irology ,Biochemistry (medical) ,Outbreak ,medicine.disease ,Printing, Three-Dimensional ,Business ,Medical emergency ,Coronavirus Infections ,AcademicSubjects/MED00690 - Abstract
The recent SARS-CoV-2 outbreak has placed immense pressure on supply chains, including shortages in nasopharyngeal (NP) swabs. Here, we report our experience of using 3D-printing to rapidly develop and deploy custom-made NP swabs to address supply shortages at our healthcare institution.
- Published
- 2020
- Full Text
- View/download PDF
8. Cooperation under Pressure: Lessons from the COVID-19 Swab Crisis.
- Author
-
Arnaout RA
- Subjects
- Humans, Nasopharynx, Pandemics, SARS-CoV-2, Specimen Handling, COVID-19
- Abstract
The early months of the COVID-19 pandemic were marked by a desperate need for nasopharyngeal swabs to test for SARS-CoV-2, with demand far outstripping supply. April marked the anniversary of an unprecedented nationwide multibusiness/multihospital partnership that successfully met this need, a fitting occasion to review lessons learned. Here, I briefly recount the key events, constraints, and thought processes surrounding the effort in order to better inform responses to future crises. Overall, the experience was a strong validation of Joy's Law and illustrated the utility of recognizing temptations to avoid, in order to reap the rewards of cooperation. I conclude by summarizing lessons learned.
- Published
- 2021
- Full Text
- View/download PDF
9. Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2.
- Author
-
Callahan C, Ditelberg S, Dutta S, Littlehale N, Cheng A, Kupczewski K, McVay D, Riedel S, Kirby JE, and Arnaout R
- Subjects
- Diagnostic Tests, Routine, Humans, Limit of Detection, Polymerase Chain Reaction methods, RNA, Viral, Sensitivity and Specificity, Time, Viral Load, COVID-19 diagnosis, COVID-19 Nucleic Acid Testing methods, Nasopharynx virology, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, Saliva virology, Specimen Handling methods
- Abstract
The continued need for molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting without restrictions to avoid food, drink, smoking, or tooth-brushing. A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity reverse transcriptase PCR (RT-PCR) platforms, the Abbott m2000 and Abbott Alinity m (both with limits of detection [LoD] of 100 copies of viral RNA/ml). Concordance between saliva and NP swabs was excellent overall (Cohen's κ = 0.93) for both initial and follow-up testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (κ = 0.88 to 0.95). Viral loads were on average 16× higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (∼8% in this study) who present with very low viral loads (<1,600 copies/ml from NP swabs) would be missed by testing saliva instead of NP swabs when using sensitive testing platforms. Special attention was necessary to ensure leak-resistant specimen collection and transport. The advantages of self-collection of saliva, without behavioral restrictions, will likely outweigh a minor potential decrease in clinical sensitivity in individuals less likely to pose an infectious risk to others for many real-world scenarios, especially for initial testing. IMPORTANCE In general, the most accurate COVID-19 testing is hands-on and uncomfortable, requiring trained staff and a "brain-tickling" nasopharyngeal swab. Saliva would be much easier on both fronts, since patients could collect it themselves, and it is after all just spit. However, despite much interest, it remains unclear how well saliva performs in real-world settings when just using it in place of an NP swab without elaborate or cumbersome restrictions about not eating/drinking before testing, etc. Also, almost all studies of COVID-19 testing, whether of NP swabs, saliva, or otherwise, have been restricted to reporting results in the abstruse units of " C
T values," which only mean something in the context of a specific assay and testing platform. Here, we compared saliva versus NP swabs in a real-world setting without restriction and report all results in natural units-the amount of virus being shed-showing that saliva is essentially just as good as NP swabs.- Published
- 2021
- Full Text
- View/download PDF
10. Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2.
- Author
-
Callahan C, Lee RA, Lee GR, Zulauf K, Kirby JE, and Arnaout R
- Subjects
- Diagnostic Tests, Routine, Humans, Nasopharynx, Specimen Handling, COVID-19, SARS-CoV-2
- Abstract
The urgent need for large-scale diagnostic testing for SARS-CoV-2 has prompted interest in sample collection methods of sufficient sensitivity to replace nasopharynx (NP) sampling. Nasal swab samples are an attractive alternative; however, previous studies have disagreed over how nasal sampling performs relative to NP sampling. Here, we compared nasal versus NP specimens collected by health care workers in a cohort of individuals clinically suspected of COVID-19 as well as SARS-CoV-2 reverse transcription (RT)-PCR-positive outpatients undergoing follow-up. We compared subjects being seen for initial evaluation versus follow-up, two different nasal swab collection protocols, and three different transport conditions, including traditional viral transport media (VTM) and dry swabs, on 307 total study participants. We compared categorical results and viral loads to those from standard NP swabs collected at the same time from the same patients. All testing was performed by RT-PCR on the Abbott SARS-CoV-2 RealTime emergency use authorization (EUA) (limit of detection [LoD], 100 copies viral genomic RNA/ml transport medium). We found low concordance overall, with Cohen's kappa (κ) of 0.49, with high concordance only for subjects with very high viral loads. We found medium concordance for testing at initial presentation (κ = 0.68) and very low concordance for follow-up testing (κ = 0.27). Finally, we show that previous reports of high concordance may have resulted from measurement using assays with sensitivity of ≥1,000 copies/ml. These findings suggest nasal-swab testing be used for situations in which viral load is expected to be high, as we demonstrate that nasal swab testing is likely to miss patients with low viral loads.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.